• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过无偏的亲和力成熟方法实现精氨酸酶 2 抑制抗体的广泛序列和结构进化。

Extensive sequence and structural evolution of Arginase 2 inhibitory antibodies enabled by an unbiased approach to affinity maturation.

机构信息

Cancer Research UK-AstraZeneca Antibody Alliance Laboratory, CB21 6GP Cambridge, United Kingdom.

Antibody Discovery & Protein Engineering, BioPharmaceuticals Research & Development, AstraZeneca, CB21 6GH Cambridge, United Kingdom.

出版信息

Proc Natl Acad Sci U S A. 2020 Jul 21;117(29):16949-16960. doi: 10.1073/pnas.1919565117. Epub 2020 Jul 2.

DOI:10.1073/pnas.1919565117
PMID:32616569
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7382286/
Abstract

Affinity maturation is a powerful technique in antibody engineering for the in vitro evolution of antigen binding interactions. Key to the success of this process is the expansion of sequence and combinatorial diversity to increase the structural repertoire from which superior binding variants may be selected. However, conventional strategies are often restrictive and only focus on small regions of the antibody at a time. In this study, we used a method that combined antibody chain shuffling and a staggered-extension process to produce unbiased libraries, which recombined beneficial mutations from all six complementarity-determining regions (CDRs) in the affinity maturation of an inhibitory antibody to Arginase 2 (ARG2). We made use of the vast display capacity of ribosome display to accommodate the sequence space required for the diverse library builds. Further diversity was introduced through pool maturation to optimize seven leads of interest simultaneously. This resulted in antibodies with substantial improvements in binding properties and inhibition potency. The extensive sequence changes resulting from this approach were translated into striking structural changes for parent and affinity-matured antibodies bound to ARG2, with a large reorientation of the binding paratope facilitating increases in contact surface and shape complementarity to the antigen. The considerable gains in therapeutic properties seen from extensive sequence and structural evolution of the parent ARG2 inhibitory antibody clearly illustrate the advantages of the unbiased approach developed, which was key to the identification of high-affinity antibodies with the desired inhibitory potency and specificity.

摘要

亲和力成熟是抗体工程中体外进化抗原结合相互作用的一种强大技术。该过程成功的关键是扩展序列和组合多样性,以增加可能被选择的更优结合变体的结构库。然而,传统策略通常具有局限性,并且一次只关注抗体的小区域。在这项研究中,我们使用了一种结合抗体链改组和交错延伸过程的方法来产生无偏库,该方法在 Arg 酶 2(ARG2)抑制性抗体的亲和力成熟过程中重新组合了所有六个互补决定区(CDR)中的有益突变。我们利用核糖体展示的巨大展示能力来容纳多样化文库构建所需的序列空间。通过池成熟进一步引入多样性,同时优化七个感兴趣的先导物。这导致了结合性质和抑制效力的显著提高。这种方法产生的广泛序列变化转化为与 ARG2 结合的亲本和亲和力成熟抗体的显著结构变化,结合变构域的大重定向促进了与抗原的接触表面和形状互补的增加。从亲本 ARG2 抑制性抗体的广泛序列和结构进化中看到的治疗性质的显著提高清楚地说明了所开发的无偏方法的优势,这是鉴定具有所需抑制效力和特异性的高亲和力抗体的关键。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99d0/7382286/2dd911770989/pnas.1919565117fig08.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99d0/7382286/bb50d26c09f3/pnas.1919565117fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99d0/7382286/4342f2f23e64/pnas.1919565117fig02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99d0/7382286/036a900bb7a7/pnas.1919565117fig03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99d0/7382286/9ea0db58b2a8/pnas.1919565117fig04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99d0/7382286/9b7631d9d701/pnas.1919565117fig05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99d0/7382286/f1a34400f91f/pnas.1919565117fig06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99d0/7382286/48f846709948/pnas.1919565117fig07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99d0/7382286/2dd911770989/pnas.1919565117fig08.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99d0/7382286/bb50d26c09f3/pnas.1919565117fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99d0/7382286/4342f2f23e64/pnas.1919565117fig02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99d0/7382286/036a900bb7a7/pnas.1919565117fig03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99d0/7382286/9ea0db58b2a8/pnas.1919565117fig04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99d0/7382286/9b7631d9d701/pnas.1919565117fig05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99d0/7382286/f1a34400f91f/pnas.1919565117fig06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99d0/7382286/48f846709948/pnas.1919565117fig07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99d0/7382286/2dd911770989/pnas.1919565117fig08.jpg

相似文献

1
Extensive sequence and structural evolution of Arginase 2 inhibitory antibodies enabled by an unbiased approach to affinity maturation.通过无偏的亲和力成熟方法实现精氨酸酶 2 抑制抗体的广泛序列和结构进化。
Proc Natl Acad Sci U S A. 2020 Jul 21;117(29):16949-16960. doi: 10.1073/pnas.1919565117. Epub 2020 Jul 2.
2
A novel heavy domain antibody library with functionally optimized complementarity determining regions.一种具有功能优化互补决定区的新型重链抗体文库。
PLoS One. 2013 Oct 8;8(10):e76834. doi: 10.1371/journal.pone.0076834. eCollection 2013.
3
Affinity maturation: highlights in the application of in vitro strategies for the directed evolution of antibodies.亲和力成熟:体外策略在抗体定向进化中的应用亮点。
Emerg Top Life Sci. 2021 Nov 12;5(5):601-608. doi: 10.1042/ETLS20200331.
4
Arginine mutations in antibody complementarity-determining regions display context-dependent affinity/specificity trade-offs.抗体互补决定区中的精氨酸突变表现出依赖于上下文的亲和力/特异性权衡。
J Biol Chem. 2017 Oct 6;292(40):16638-16652. doi: 10.1074/jbc.M117.783837. Epub 2017 Aug 4.
5
Probing a protein-protein interaction by in vitro evolution.通过体外进化探究蛋白质-蛋白质相互作用。
Proc Natl Acad Sci U S A. 2006 May 16;103(20):7619-24. doi: 10.1073/pnas.0602341103. Epub 2006 May 9.
6
Antibody VH and VL recombination using phage and ribosome display technologies reveals distinct structural routes to affinity improvements with VH-VL interface residues providing important structural diversity.利用噬菌体和核糖体展示技术进行抗体 VH 和 VL 重组揭示了亲和力提高的独特结构途径,其中 VH-VL 界面残基提供了重要的结构多样性。
MAbs. 2014 Jan-Feb;6(1):236-45. doi: 10.4161/mabs.27261.
7
Affinity maturation of a humanized rat antibody for anti-RAGE therapy: comprehensive mutagenesis reveals a high level of mutational plasticity both inside and outside the complementarity-determining regions.用于抗RAGE治疗的人源化大鼠抗体的亲和力成熟:全面诱变揭示了互补决定区内外的高度突变可塑性。
J Mol Biol. 2009 May 8;388(3):541-58. doi: 10.1016/j.jmb.2009.03.019. Epub 2009 Mar 13.
8
The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies.人源组合抗体文库HuCAL GOLD将基于天然免疫系统的所有六个互补决定区(CDR)的多样化与一种用于高效筛选高亲和力抗体的新型展示方法结合在一起。
J Mol Biol. 2008 Feb 29;376(4):1182-200. doi: 10.1016/j.jmb.2007.12.018. Epub 2007 Dec 15.
9
Phage-displayed antibody libraries of synthetic heavy chain complementarity determining regions.合成重链互补决定区的噬菌体展示抗体文库。
J Mol Biol. 2004 Apr 23;338(2):299-310. doi: 10.1016/j.jmb.2004.02.050.
10
Improving antibody binding affinity and specificity for therapeutic development.提高抗体结合亲和力和特异性以促进治疗性开发。
Methods Mol Biol. 2009;525:353-76, xiii. doi: 10.1007/978-1-59745-554-1_19.

引用本文的文献

1
Genotype-phenotype landscapes for immune-pathogen coevolution.免疫病原体协同进化的基因型-表型景观。
Trends Immunol. 2023 May;44(5):384-396. doi: 10.1016/j.it.2023.03.006. Epub 2023 Apr 4.
2
Simultaneous affinity maturation and developability enhancement using natural liability-free CDRs.利用天然无不良倾向的 CDR 同时进行亲和力成熟和可开发性增强。
MAbs. 2022 Jan-Dec;14(1):2115200. doi: 10.1080/19420862.2022.2115200.
3
Cryo-EM structures of inhibitory antibodies complexed with arginase 1 provide insight into mechanism of action.

本文引用的文献

1
Insights into the Structural Basis of Antibody Affinity Maturation from Next-Generation Sequencing.从下一代测序中洞察抗体亲和力成熟的结构基础。
Front Immunol. 2018 Feb 1;9:117. doi: 10.3389/fimmu.2018.00117. eCollection 2018.
2
The diversity of H3 loops determines the antigen-binding tendencies of antibody CDR loops.H3环的多样性决定了抗体互补决定区环的抗原结合倾向。
Protein Sci. 2016 Apr;25(4):815-25. doi: 10.1002/pro.2874. Epub 2016 Jan 20.
3
Affinity maturation of a novel antagonistic human monoclonal antibody with a long VH CDR3 targeting the Class A GPCR formyl-peptide receptor 1.
抑制性抗体与精氨酸酶 1 复合物的冷冻电镜结构提供了对作用机制的深入了解。
Commun Biol. 2021 Jul 29;4(1):927. doi: 10.1038/s42003-021-02444-z.
4
Affinity maturation: highlights in the application of in vitro strategies for the directed evolution of antibodies.亲和力成熟:体外策略在抗体定向进化中的应用亮点。
Emerg Top Life Sci. 2021 Nov 12;5(5):601-608. doi: 10.1042/ETLS20200331.
5
Surprisingly Fast Interface and Elbow Angle Dynamics of Antigen-Binding Fragments.抗原结合片段惊人快速的界面和肘部角度动力学
Front Mol Biosci. 2020 Nov 24;7:609088. doi: 10.3389/fmolb.2020.609088. eCollection 2020.
6
Revisiting the phosphotyrosine binding pocket of Fyn SH2 domain led to the identification of novel SH2 superbinders.重新研究 Fyn SH2 结构域的磷酸酪氨酸结合口袋导致了新型 SH2 超级结合物的鉴定。
Protein Sci. 2021 Mar;30(3):558-570. doi: 10.1002/pro.4012. Epub 2020 Dec 31.
7
Structural and functional characterization of C0021158, a high-affinity monoclonal antibody that inhibits Arginase 2 function via a novel non-competitive mechanism of action.C0021158的结构与功能特性,一种通过新型非竞争性作用机制抑制精氨酸酶2功能的高亲和力单克隆抗体。
MAbs. 2020 Jan-Dec;12(1):1801230. doi: 10.1080/19420862.2020.1801230.
一种新型拮抗性人单克隆抗体的亲和力成熟,该抗体具有靶向 A 类 G 蛋白偶联受体甲酰肽受体 1 的长 VH CDR3。
MAbs. 2015;7(1):152-66. doi: 10.4161/19420862.2014.985158.
4
Versatility of homogeneous time-resolved fluorescence resonance energy transfer assays for biologics drug discovery.用于生物制品药物发现的均相时间分辨荧光共振能量转移分析方法的多功能性
J Biomol Screen. 2015 Apr;20(4):508-18. doi: 10.1177/1087057114557464. Epub 2014 Nov 7.
5
Antibody VH and VL recombination using phage and ribosome display technologies reveals distinct structural routes to affinity improvements with VH-VL interface residues providing important structural diversity.利用噬菌体和核糖体展示技术进行抗体 VH 和 VL 重组揭示了亲和力提高的独特结构途径,其中 VH-VL 界面残基提供了重要的结构多样性。
MAbs. 2014 Jan-Feb;6(1):236-45. doi: 10.4161/mabs.27261.
6
How good are my data and what is the resolution?我的数据质量如何,分辨率是多少?
Acta Crystallogr D Biol Crystallogr. 2013 Jul;69(Pt 7):1204-14. doi: 10.1107/S0907444913000061. Epub 2013 Jun 13.
7
Development of a homogeneous high-throughput screening assay for biological inhibitors of human rhinovirus infection.用于人鼻病毒感染生物抑制剂的均相高通量筛选检测方法的开发。
J Biomol Screen. 2013 Mar;18(3):237-46. doi: 10.1177/1087057112469047. Epub 2012 Dec 3.
8
Optimisation of antibody affinity by ribosome display using error-prone or site-directed mutagenesis.利用易错或定点诱变通过核糖体展示优化抗体亲和力。
Methods Mol Biol. 2012;805:139-61. doi: 10.1007/978-1-61779-379-0_9.
9
Ribosome display: a perspective.核糖体展示:一种观点。
Methods Mol Biol. 2012;805:3-28. doi: 10.1007/978-1-61779-379-0_1.
10
Whole-molecule antibody engineering: generation of a high-affinity anti-IL-6 antibody with extended pharmacokinetics.全分子抗体工程:生成具有延长药代动力学的高亲和力抗 IL-6 抗体。
J Mol Biol. 2011 Aug 26;411(4):791-807. doi: 10.1016/j.jmb.2011.06.031. Epub 2011 Jun 23.